Osteoporosis Market Research Reports & Industry Analysis
Osteoporosis is characterized by decreased bone mineral density (BMD) and deterioration of the bone microarchitecture, a combination of factors that lead to an increased risk of fracture. Osteoporosis affects hundreds of millions of people worldwide, in developed and undeveloped nations. The prevalence of osteoporosis is projected to increase considerably as the global population ages and life expectancy increases as anticipated. The Office of the Surgeon General in the U.S. warns that osteoporosis may become an epidemic if people do not make the adjustments in nutrition, supplementation, and physical activity necessary to prevent osteoporosis.
The overall cost of osteoporosis fractures and their complications poses a considerable burden for healthcare systems around the world; osteoporosis costs are comparable with those of other major chronic diseases, such as cardiovascular diseases and asthma. In addition, osteoporosis fractures are a major cause of disability and morbidity among older people; an estimated fifth of patients who experience an osteoporotic hip fracture die due to complications within 1 year after the fracture. Drug therapies that are capable of addressing osteoporosis and reducing the risk of fractures could bring economic benefits to governments and healthcare providers and improve the quality of life for osteoporosis patients.
Osteoporosis Industry Research & Market Reports
-
Osteoporosis Drugs Markets in China
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More
-
Osteoporosis Drugs Industry Forecasts - China Focus
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Osteoporosis Drugs Companies in China
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
Bone Densitometers
... for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these ... Read More
-
Osteoporosis: Global Drug Forecast and Market Analysis to 2027
... of the bone cells dissolve (resorption) and new bone cells grow back (formation). For people with osteoporosis, bone loss outpaces the growth of new bone. Consequently, bones become more porous and fragile, leading to weakness ... Read More
-
Global Osteoporosis Drugs Market 2019-2023
... population. Therefore, major markets such as the US, Germany, Japan, the UK, France, Canada, Spain, and other developed European countries are providing reimbursement schemes. Technavio’s analysts have predicted that the osteoporosis drugs market will register ... Read More
-
Hyaluronic Acid Market Size, Share, Growth - Segmented by Application (Cosmetics, Osteoarthritis, and Others), and Geography - Growth, Trends and Forecasts (2019 - 2024)
... at a CAGR of 9.8% till 2024. Hyaluronic acid is a naturally occurring chemical in the Human body which has many functions from moisturizing to damage reduction and acts as a natural fluid. It is ... Read More
-
The 2020-2025 World Outlook for Osteoporosis Therapeutics
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Bisphosphonates
... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More
-
The 2020-2025 World Outlook for Osteoporosis Drugs
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
Regulatory Trends in German Bone Mineral Density Solutions, 2017
... Product Registration & CE Approval Process in Germany • Regulatory Requirements for Product Registration for DEXA-BMD device in Germany • Phantom Testing – Calibrations and Quality Check for the DEXA-BMD device • Recommended Young Adult ... Read More
-
Osteoporosis - Pipeline Review, H2 2018
... or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Signs and symptoms include ... Read More
-
Post Menopausal Osteoporosis - Pipeline Review, H2 2018
... Osteoporosis (Metabolic Disorders) pipeline landscape. Postmenopausal osteoporosis is the most common form of osteoporosis. It affects many women after menopause. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. Risk ... Read More
-
Musculoskeletal Diseases Treatment Market to 2025 - Global Analysis and Forecasts By Type (Arthritis, Osteoarthritis, Osteoporosis, Spondylitis, and Others); Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Oth
... The global musculoskeletal diseases treatment market is expected to reach US$ 5,730.8 Mn in 2025 from US$ 3,837.9 in 2017. The musculoskeletal diseases treatment market is estimated to grow with a CAGR of 5.3% from ... Read More
-
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness
... WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone ... Read More
-
Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2018
... report provides top line data relating to the clinical trials on Post Menopausal Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Osteoporosis Global Clinical Trials Review, H1, 2018
... to the clinical trials on Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ... Read More
-
Osteoarthritis Pain Global Clinical Trials Review, H1, 2018
... line data relating to the clinical trials on Osteoarthritis Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
-
Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023
... market projected to grow at a CAGR of 8.0%” The global veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% ... Read More
-
Osteoporosis: Epidemiology Forecast to 2027
... cells dissolve (resorption) and new bone cells grow back (formation). The bones become so weak and brittle that a fall or even mild stresses such as bending over or coughing can cause a fracture. To ... Read More
-
Intranasal Drug Delivery (Allergic Infections, Analgesics, Osteoporosis, and Vaccinations.)
... estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for this market. Market data and analytics are derived from primary and secondary research. Company profiles are ... Read More
-
Global Bone & Joint Health Ingredients Market - Growth,Trends and Forecast (2018 - 2023)
... Health Organization (WHO) The global population particularly in the developed economies are approaching ages nearing or surpassing the life expectancy of human beings and maintaining bone and joint health becomes very crucial, the market for ... Read More
-
Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022
... market is projected to grow at a CAGR of 6.0% during the forecast period” The global injection pen market is expected to reach USD 41.38 billion by 2022 from an estimated USD 30.97 billion in ... Read More
-
The 2019-2024 World Outlook for Osteoporosis Drugs
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2019-2024 World Outlook for Osteoporosis Therapeutics
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
